A medical nanodevice for non ventilatory oxygenation.

Now raising funding!

We are looking for private capital while in evaluation for the EUROSTARS European funding.

As for the Coronavirus rapid spread, we've decided to accelerate the GLOWIT R&D to obtain a functional molecule in about 6 weeks.

As GLOWIT may oxygenate bypassing the lungs, it may be used as a support treatment in Respiratory Failure which is the cause of death in Coronavirus infection. 

Support us directly, contact us for more details by:



-Telephone: +34 675854656

©2020 by Ceiimed. All the information cited here may be used only with permission.